Search
Friday 10 April 2015
  • :
  • :

Stocks Going Down: Pilgrim’s Pride Corporation (NASDAQ:PPC), Motorola Solutions, (NYSE:MSI), Novavax, (NASDAQ:NVAX), Avis Budget Group, (NASDAQ:CAR)

On Monday, Pilgrim’s Pride Corporation (NASDAQ:PPC)’s shares declined -1.76%, and closed at $24.01, as Pilgrim’s Pride, on April 2, declared the launch of a new corporate website, www.pilgrims.com, which provides information on the corporation, its products, team members, growers, culture, and history, in addition to meal ideas and recipes for consumers.

The redesigned website provides a one-stop location for customers, consumers and investors seeking information about the family farmers who raise Pilgrim’s chickens, the team members who produce the well-known, high quality Pilgrim’s products and the corporation’s story and philosophy.

Visitors can find in-depth product information regarding all Pilgrim’s offerings, from fresh chicken to fully-cooked and ready-to-cook options. Additionally, the site provides an interactive Fresh Trace program tool, which allows customers and consumers to enter a package code and learn exactly where that product came from.

Pilgrim’s Pride Corporation engages in the production, processing, marketing, and distribution of fresh, frozen, and value-added chicken products to retailers, distributors, and foodservice operators in the United States, Mexico, and Puerto Rico.

Motorola Solutions, Inc. (NYSE:MSI)’s shares dropped -1.65%, and settled at $61.48, during the last trading session on Monday, as Motorola, on April 1, attained PublicEngines, a privately held provider of cloud-based solutions that deliver crime analysis, predictive policing and citizen engagement capabilities for law enforcement agencies, governments and other organizations.

This attainment advances Motorola Solutions’ strategy to revolutionize public safety’s use of accessible data to gain actionable intelligence to support its mission. The combination of CommandCentral with Motorola Solutions’ situational awareness offerings will establish an unmatched platform for delivery of intelligence-led public safety capabilities. Additionally, the citizen engagement products bolster the corporation’s ability to assist agencies openly and transparently interact with citizens to create safer and better-informed communities.

Motorola Solutions, Inc. provides mission-critical communication infrastructure, devices, software, and services in North America, Latin America, the Asia Pacific, the Middle East, Europe, and Africa. The corporation operates in two segments, Products and Services. The Products segment offers a portfolio of network infrastructure, devices, accessories, and software for government, public safety and first-responder agencies, municipalities, and commercial and industrial customers.

At the end of Monday’s trade, Novavax, Inc. (NASDAQ:NVAX)’s shares dipped -1.64%, and closed at $7.81, as Novavax on March 31, declared the closing of the underwritten public offering priced on Wednesday, March 25, 2015.

The corporation issued 27,758,620 shares of its ordinary stock, counting 3,620,689 shares following the underwriters’ option to purchase additional shares. The shares were issued at $7.25 per share resulting in total gross proceeds from this offering of about $201,250,000 before deducting the underwriters discount and offering expenses.

J.P. Morgan and Citigroup acted as joint book-running managers of the offering. Piper Jaffray & Co. and Wedbush PacGrow acted as Co-Lead Managers, Janney Montgomery Scott and Ladenburg Thalmann acted as Co-Managers.

Novavax, Inc., a clinical-stage vaccine corporation, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The corporation produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline comprises respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization that are in Phase II clinical trials, in addition to pediatric respiratory syncytial virus candidate, which is in Phase I clinical trial; seasonal quadrivalent influenza and pandemic H7N9 vaccines, which are in Phase I clinical trials; vaccine candidate against Ebola Virus that is Phase I clinical trial, in addition to combination respiratory vaccine candidate, which is pre-clinical trial; and seasonal influenza vaccine candidate that is Phase III clinical trial, in addition to rabies G protein vaccine candidate, which is in Phase 1/2 clinical trial.

Avis Budget Group, Inc. (NASDAQ:CAR), ended its Monday’s trading session with -1.58% loss, and closed at $56.54, as on April 2, Zipcar, the world’s leading car-sharing network, a partner of Avis Budget launched its service in Istanbul. Istanbul marks Zipcar’s sixth European city and with Istanbul straddling Europe and Asia, its first footstep into Asia.

Massimo Marsili, President, Zipcar International, said: “With a population of over 14 million, Istanbul is one of the largest cities in the world, and like many of the cities where we operate, is challenged with increasing pressure on the transport infrastructure and the environmental influence of congestion in the city. We are delighted to be able to provide an alternative mobility solution to residents in Istanbul and to play our part in assisting to reduce congestion in the city. Our service is environmentally friendly, complementary to public transportation and ideal for a new generation of smart consumers who are looking for goods and services that are accessible on demand.”

Avis Budget Group, Inc., together with its auxiliaries, provides car and truck rentals, car sharing, and ancillary services to businesses and consumers worldwide. The corporation has three segments: North America, International, and Truck Rental.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *